March 18 (Reuters) - Spyre Therapeutics Inc SYRE.O :
* SPYRE THERAPEUTICS ANNOUNCES $180 MILLION PRIVATE
PLACEMENT
* SPYRE THERAPEUTICS INC - EXPECTS THAT NET PROCEEDS WILL
EXTEND
ITS CASH RUNWAY TO FUND ITS OPERATING PLAN WELL INTO 2027
* SPYRE THERAPEUTICS - PIPE FINANCING INCLUDED
PARTICIPATION FROM
ADAGE CAPITAL PARTNERS LP, AVIDITY PARTNERS, BOXER CAPITAL,
DARWIN GLOBAL MANAGEMENT
* SPYRE THERAPEUTICS: INTENDS TO USE NET PROCEEDS FROM PIPE
FINANCING,EXISTING CASH,CASH EQUIVALENTS & MARKETABLE
SECURITIES, TO FUND PIPELINE PROGRAMS
* SPYRE THERAPEUTICS-PIPE FINANCING INCLUDED PARTICIPATION
FROM
DEEP TRACK CAPITAL, FUNDS AFFILIATED WITH FARALLON CAPITAL
MANAGEMENT LLC. LOGOS CAPITAL
Source text for Eikon: ID:nPn4741tfa
Further company coverage: SYRE.O